Free tools Windows power users keep installed
One-click scans. No signup required.
Researchers have engineered yeast to produce QS-21, a saponin-based vaccine adjuvant, from simple sugars. The result points to a possible alternative to harvesting the compound from soapbark tree bark—but the reported yeast output remains low, and substantial optimization is needed before the method could support production at scale.
What QS-21 is and why it matters
QS-21 is a saponin-based adjuvant: an ingredient added to some vaccines to help strengthen the immune response. Chemistry World reported in May 2024 that it was the only saponin-based adjuvant approved for clinical use in commercial vaccines, citing its use in shingles, malaria and COVID-19 vaccines. An adjuvant is not the vaccine’s target antigen; it helps shape the body’s response to that antigen.
As an Amazon Associate I earn from qualifying purchases.
Its value makes a dependable supply important. The conventional source described in the report is the bark of Quillaja saponaria, or soapbark, a tree found in Chile. Harvesting is regulated, mature trees are needed, and extracting and purifying QS-21 from the other substances in bark is difficult and low-yielding.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →How engineered yeast makes QS-21
The team used glucose and galactose as feedstocks and rewired yeast’s metabolism to build the molecule. It first tuned the yeast’s native mevalonate pathway to make quillaic acid, a key precursor to QS-21. Researchers then used CRISPR genome editing to add genes encoding enzymes that complete later steps.
#1 Best Overall
A long pathway assembled from multiple organisms
According to Chemistry World’s May 2024 account, the engineered strain incorporated 38 enzymes across seven enzyme families, with enzyme-encoding genes from six other organisms. Those sources included plants with structurally similar saponins, as well as fungi and bacteria. The researchers designed the pathway to avoid disrupting processes yeast needs to grow and survive. The report describes it as one of the longest biosynthetic pathways transplanted into an organism.
The work built on an earlier milestone: a 20-step QS-21 biosynthetic pathway identified by some of the same team and reproduced in tobacco. Chemistry World cites Y. Liu and colleagues’ 2024 paper in Nature, DOI 10.1038/s41586-024-07345-9.
Rank #2
- Used Book in Good Condition
What the production figures do—and do not—show
After three days, the engineered yeast produced around one-third as much QS-21 as soapbark tree cells, according to the Chemistry World report. That is a comparison of amounts produced over the stated period, not evidence that the yeast already outproduces trees.
Do these 3 things before closing this tab:
1Repair Windows errors before they cause bigger problems2Scan for outdated or missing drivers - takes under a minute3Clear out junk files and repair common Windows errorsJay Keasling, who spearheaded the work, separately described yeast as around 1,000 times faster than trees. He was comparing production time, noting that only mature trees produce QS-21; this is not a direct yield-per-batch, cost or commercial-capacity comparison. Keasling said the yeast route could be cheaper even at the reported production level, but the report gives no cost model or quantified estimate to verify that claim.
Rank #3
- Used Book in Good Condition
How the yeast route compares with other sources
| Approach | Source or feedstock | What the May 2024 report establishes |
|---|---|---|
| Tree-bark extraction | Bark from mature soapbark trees | Harvesting is regulated; extraction and purification are described as laborious, costly and low-yielding. |
| Plant tissue culture | Soapbark seedlings grown in a laboratory | Identified as another production direction; comparative yield, cost and commercial supply figures are not stated in the report. |
| Cultured plant cells | Plant cells grown in culture | An industry-led route was reported in March 2024; comparative yield, cost and commercial supply figures are not stated in the report. |
| Engineered yeast | Yeast fed glucose and galactose | Produced around one-third the amount made by soapbark tree cells after three days; the report says significant yield optimization is still needed for viable scale production. |
The available figures do not support ranking these approaches by cost, yield or commercial readiness. Each route also has different feedstocks and process requirements, and the report does not provide a head-to-head comparison.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Can yeast replace the soapbark tree?
Not yet, based on the evidence reported in May 2024. The experiment demonstrates that engineered yeast can make QS-21 from sugars, but the output was well below that of soapbark tree cells in the reported three-day comparison. Paul Race, a natural-product biosynthesis researcher at Newcastle University, said significant optimization was still required to achieve yields suitable for viable production at scale.
The report establishes a proof of concept, not a commercially available supply route. It does not verify whether yeast-produced QS-21 has since entered commercial production.
Quick Recap
Best Value
Sources
- James Urquhart, “Genetic engineering feat coaxes yeast to produce valuable vaccine compound,” Chemistry World, May 30, 2024: chemistryworld.com.
- Y. Liu et al., Nature (2024), DOI 10.1038/s41586-024-07345-9.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
